![James V. Desiderio](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di James V. Desiderio
Precedenti posizioni note di James V. Desiderio
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACCELERON PHARMA INC. | Consigliere Generale | 01/04/2007 | 01/12/2021 |
CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | - | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | - | - |
IDENIX PHARMACEUTICALS INC | Direttore/Membro del Consiglio | - | - |
Corporate Officer/Principal | - | - |
Formazione di James V. Desiderio
Long Island University | Undergraduate Degree |
College of Veterinary Medicine | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
Corporate Officer/Principal | 4 |
Undergraduate Degree | 2 |
General Counsel | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Aziende private | 3 |
---|---|
Acceleron Pharma, Inc.
![]() Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
Idenix Pharmaceuticals LLC
![]() Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- James V. Desiderio
- Esperienza